The age-old advice to "trust your gut" could soon take on new meaning for people diagnosed with Parkinson's disease, thanks ...

Valo will use its trove of patient records and biobank samples to pinpoint potential targets for Merck’s pipeline expansion.

Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused ...

Merck KGaA has teamed up with Flagship Pioneering's Valo Health on an ambitious project to apply AI to the discovery of novel ...

A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with this condition worldwide, daily treatment has meant taking levodopa and ...

Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrum Positive results across all three Phase 3 TEMPO trials ...

Keith Krehbiel lived with Parkinson’s disease for nearly 25 years before agreeing to try a brain implant that might alleviate his symptoms. He had long been reluctant to submit to the surgery. “It was ...

A drug first developed in the 1950s for Parkinson’s disease may be an unexpected ally in the global fight against tuberculosis, according to new research from the University of British Columbia (UBC).

A medication developed in the 1950s to treat Parkinson’s disease may offer a powerful new tool in the fight against tuberculosis (TB), according to new research from the University of British Columbia ...

Researchers in the University of Georgia's College of Veterinary Medicine have engineered a live bacterium to function as the ...